Orchard Therapeutics - U.S. Email Format
Biotechnology ResearchEngland, United Kingdom201-500 Employees
Orchard Therapeutics - U.S. is a biotechnology research company focused on hematopoietic stem cell gene therapy, aiming to treat genetic and other severe diseases by editing a patient’s own blood stem cells outside the body and reinserting them. It describes itself as a global gene therapy leader and operates as part of Kyowa Kirin, following its acquisition in 2024. Founded in 2015, Orchard’s work draws on early research in HSC gene therapy and it is developing a pipeline of therapies for diseases with limited current options. The company has 201-500 employees and is located at 245 Hammersmith Road, 3rd Floor, London, United Kingdom; its website is https://orchard-tx.com. Recent expansions include growing its U.S. footprint with a manufacturing facility added in Fremont, California to support ex vivo gene therapy programs.